REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
9.73
-0.52 (-5.07%)
Jul 24, 2026, 4:00 PM EDT - Market closed
REGENXBIO Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 87.82 | 170.44 | 83.33 | 90.24 | 112.72 | 470.35 |
Revenue Growth | -43.96% | 104.54% | -7.66% | -19.94% | -76.03% | 204.30% |
Gross Profit Gross Profit Growth | 59.89 | 150.14 | 49.76 | 53.03 | 58.18 | 418.51 |
Operating Income Operating Income Growth | -256.69 | -161.2 | -233.35 | -268.13 | -262.88 | 159.98 |
Net Income Net Income Growth | -290.01 | -193.88 | -227.1 | -263.49 | -280.32 | 127.84 |
Earnings Per Share EPS Growth | -5.60 | -3.76 | -4.59 | -6.02 | -6.50 | 2.91 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Japan Japan Growth | 74.99 | - | - | - | - |
United States United States Growth | 42.61 | 30 | 28.88 | 39.45 | 32.92 |
Germany Germany Growth | - | 8.33 | - | 11.27 | - |
United Arab Emirates United Arab Emirates Growth | - | 8.33 | - | - | - |
Foreign Foreign Growth | 52.84 | 36.66 | 61.36 | 62 | 65.85 |
Total Total Growth | 170.44 | 83.33 | 90.24 | 112.72 | 470.35 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 150.49 | 230.07 | 234.69 | 275.26 | 364.64 | 457.44 |
Total Debt Total Debt Growth | 248.4 | 260.52 | 141.72 | 183.34 | 232.41 | 258.03 |
Net Cash (Debt) Net Cash Growth | -97.91 | -30.45 | 92.97 | 91.92 | 132.24 | 199.41 |
Net Cash Growth | - | - | 1.14% | -30.49% | -33.69% | -4.95% |
Net Cash Per Share Net Cash Per Share Growth | -1.89 | -0.59 | 1.88 | 2.10 | 3.06 | 4.54 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -233.78 | -123.96 | -173.13 | -218.41 | -207.49 | 218.88 |
Capital Expenditures CapEx Growth | -2.63 | -2.41 | -2.44 | -9.96 | -30.72 | -84.18 |
Free Cash Flow Free Cash Flow Growth | -236.4 | -126.38 | -175.56 | -228.37 | -238.21 | 134.7 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 68.19% | 88.09% | 59.72% | 58.76% | 51.61% | 88.98% |
Operating Margin | -292.28% | -94.58% | -280.03% | -297.12% | -233.20% | 34.01% |
Pretax Margin | -330.23% | -113.75% | -272.54% | -292.15% | -248.75% | 30.03% |
Profit Margin | -330.23% | -113.75% | -272.54% | -291.99% | -248.68% | 27.18% |
FCF Margin | -269.18% | -74.15% | -210.69% | -253.06% | -211.32% | 28.64% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 11.24 |
Forward PE | - | 35.95 | 54.68 | 54.68 | 54.68 | 76.17 |
P/FCF Ratio | - | - | - | - | - | 10.40 |
PS Ratio | 6.84 | 4.30 | 4.60 | 8.76 | 8.71 | 2.98 |